What does Shine-On BioMedical Co.,Ltd. do?

Shine-On BioMedical Co.,Ltd. (6926.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6926.TWO's market cap?

Shine-On BioMedical Co.,Ltd. (6926.TWO) has a market capitalization of approximately $3.09 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6926.TWO pay a dividend?

No — Shine-On BioMedical Co.,Ltd. (6926.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6926.TWO profitable?

Shine-On BioMedical Co.,Ltd. (6926.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6926.TWO

Shine-On BioMedical Co.,Ltd.

TWO·Biotechnology · Healthcare

NT$62.00NT$1.60−2.52%

Market capNT$3.09B·Aug 26 6:59 AM UTC

Price Chart

NT$62.00−NT$1.60 (−2.52%)today

−17.44%CAGR −4.98%

Select date range

FromTo

Nov 25, 2022Nov 25, 2022 → Aug 26, 2026· 3.8 yrsAug 26, 2026

Key Metrics

6926.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$50.62M

Net Income−NT$181.72M

Net Margin−359.0%

Operating Cash Flow−NT$143.38M

Capital ExpendituresNT$1.05M

Free Cash Flow−NT$144.43M

Return on Equity−23.0%

Return on Invested Capital−15.4%

Net CashNT$808.13M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6926.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6926.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6926.TWO and 80,000+ other tickers.

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.

CEO: Hongzhe Jiang
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 22
Website: www.shineon-bio.com

Peers

Peers Tab

3205.TWO

Sagittarius Life Science Corp

Cap

NT$3.2B

6610.TWO

TWi Biotechnology, Inc.

Cap

NT$6.6B

1777.TWO

SYN-TECH Chem. & Pharm. Co., Ltd.

Cap

NT$3.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6926.TWO

What does Shine-On BioMedical Co.,Ltd. do?: Shine-On BioMedical Co.,Ltd. (6926.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6926.TWO's market cap?: Shine-On BioMedical Co.,Ltd. (6926.TWO) has a market capitalization of approximately $3.09 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6926.TWO pay a dividend?: No — Shine-On BioMedical Co.,Ltd. (6926.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6926.TWO profitable?: Shine-On BioMedical Co.,Ltd. (6926.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.